Tag: MDMA

2017 Look Back – 2018 Look Forward

2017For this end-of-the-year/start-of-the-year  How on Earth show, we look back to 2017 with clips from some of our features from the past year: selections about tracking methane leaks, ketogenic diets, using MDMA to treat PTSD, gravitational waves, the solar eclipse, space missions, and the politicization of science.  Those are just a few of the topics we covered in 2017, which also included: the continuation of the Our Microbes, Ourselves series, global warming and climate change, research about aging, mutant proteins, how humans have altered nature, future technologies, nuclear tests and the Van Allen belts, biofuels, extinctions following an asteroid impact, monorails, life expectancy in America,  observing stellar occultations by objects in the distant solar system, space shields for satellites, virtual colonoscopies, the Search for Extraterrestrial Intelligence (SETI), chronic fatigue syndrome, protecting pollinators, testing our drinking water, cancer, the Long Now foundation, citizen science, fracking, and more!

Hosts: Joel Parker, Susan Moran
Producer, Engineer: Joel Parker
Additional Contributions: Beth Bennett, Shelley Schlender
Executive Producer: Susan Moran

Listen to the show:

Play

Podcast: Play in new window | Download (Duration: 25:19 — 34.8MB)

Subscribe: RSS

Clinical Trials Test MDMA as PTSD Treatment

Artwork credit: MDMA trial participant Allison Heistand-Phelps
Artwork credit: MDMA trial participant Allison Heistand-Phelps

This week on How on Earth host Susan Moran interviews two investigators of FDA-approved clinical trials testing the efficacy and safety of the illegal drug MDMA — known in an altered form as Ecstasy or Molly — as a treatment (along with psychotherapy sessions) for Post-Traumatic Stress Syndrome. Our guests are Marcela Ot’alora and Bruce Poulter, investigators of the Colorado trial. Marcela is a licensed psychotherapist and Bruce is a registered nurse with a masters degree in public health

PTSD is an anxiety disorder that affects up to one in 12 people in the United States, and it’s at least as common in some other countries. It is a serious, and costly, public health problem. If the trials are successful,  MDMA, which has its critics, could become commercially available as a medically prescribed treatment by 2021. The trials are being funded by a nonprofit organization, the Multidisciplinary Association for Psychedelic Studies (MAPS), which promotes careful and beneficial uses of psychedelics and marijuana.

Hosts: Susan Moran, Joel Parker
Producer: Susan Moran
Engineer: Joel Parker
Executive Producer: Joel Parker

Listen to the show:

Play

Podcast: Play in new window | Download (Duration: 27:08 — 24.8MB)

Subscribe: RSS